The Company is primarily engaged, directly and indirectly (i) in the business of contract development and organizationservices, ranging from discovery clinical development to commercial manufacturing of active pharmaceutical ingredients,formulations; (ii) in the business of manufacturing, selling and distribution of complex hospital generics includinginhalation anesthesia injectable anaesthesia, intrathecal spasticity and pain management and select antibiotics; and (iii)developing and marketing of consumer healthcare products.
In 2020 :
-The Company was incorporated on March 4, 2020.
-Acquired pharmaceutical business from PEL.
-The Company shares was listed on bombay stock exchange on October 19, 2020.
In 2021 :
-Acquisition of HPPL.
-Acquisition of minority stake in Yapan Bio Private Limited.
In 2024:The Company was listed on Metroploitan Stock Exchange on May 16, 2024.
Legal Address
Ground Floor, Piramal Ananta,, Agastya Corporate Park, Kamani Junction
Mumbai; Maharashtra;
Postal Code: 400070
Contact Details: Purchase the Piramal Pharma Ltd. report to view the information.
Website: http://www.piramalpharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service